Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 18 | 2024 | 518 | 4.300 |
Why?
|
Lung Diseases, Interstitial | 19 | 2024 | 939 | 4.070 |
Why?
|
Scleroderma, Systemic | 9 | 2024 | 346 | 2.190 |
Why?
|
Pulmonary Fibrosis | 6 | 2023 | 503 | 1.530 |
Why?
|
Collagen Type I | 3 | 2023 | 615 | 1.190 |
Why?
|
Molecular Imaging | 5 | 2023 | 822 | 1.080 |
Why?
|
Gallium Radioisotopes | 3 | 2023 | 195 | 0.980 |
Why?
|
Continuous Positive Airway Pressure | 6 | 2014 | 581 | 0.830 |
Why?
|
Lung | 20 | 2024 | 10033 | 0.820 |
Why?
|
Fibrosis | 8 | 2023 | 2070 | 0.650 |
Why?
|
Sleep Apnea, Obstructive | 5 | 2014 | 1896 | 0.580 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 359 | 0.550 |
Why?
|
Dyspnea | 4 | 2024 | 1352 | 0.490 |
Why?
|
Autoantibodies | 3 | 2020 | 2113 | 0.470 |
Why?
|
Organometallic Compounds | 1 | 2018 | 644 | 0.460 |
Why?
|
Bronchiolitis Obliterans | 1 | 2016 | 221 | 0.460 |
Why?
|
Collagen | 2 | 2023 | 2618 | 0.440 |
Why?
|
Positron-Emission Tomography | 5 | 2024 | 6547 | 0.440 |
Why?
|
Gadolinium | 1 | 2018 | 965 | 0.420 |
Why?
|
Lysophospholipids | 2 | 2022 | 335 | 0.410 |
Why?
|
Sleep Apnea, Central | 1 | 2013 | 88 | 0.410 |
Why?
|
Masks | 1 | 2013 | 209 | 0.360 |
Why?
|
Pneumonia | 1 | 2023 | 2157 | 0.360 |
Why?
|
Vascular Diseases | 1 | 2018 | 1159 | 0.330 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1604 | 0.320 |
Why?
|
Biomedical Research | 1 | 2024 | 3458 | 0.300 |
Why?
|
Capillary Permeability | 2 | 2022 | 768 | 0.280 |
Why?
|
Autoantigens | 2 | 2020 | 883 | 0.240 |
Why?
|
Humans | 56 | 2024 | 765956 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 7 | 2023 | 36532 | 0.220 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2023 | 24 | 0.220 |
Why?
|
Models, Biological | 1 | 2019 | 9443 | 0.200 |
Why?
|
Lung Injury | 2 | 2024 | 430 | 0.200 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 326 | 0.200 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 78 | 0.200 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13451 | 0.190 |
Why?
|
Fibrin | 1 | 2024 | 513 | 0.190 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2023 | 214 | 0.170 |
Why?
|
Pseudomonas Infections | 1 | 2023 | 622 | 0.160 |
Why?
|
Research Subjects | 1 | 2021 | 247 | 0.150 |
Why?
|
Tissue Distribution | 1 | 2022 | 2266 | 0.150 |
Why?
|
Indoles | 2 | 2024 | 1839 | 0.150 |
Why?
|
Critical Care | 2 | 2021 | 2712 | 0.150 |
Why?
|
Ephrin-B2 | 1 | 2017 | 40 | 0.140 |
Why?
|
Blood Pressure | 2 | 2014 | 8532 | 0.140 |
Why?
|
Receptors, Chemokine | 1 | 2021 | 651 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 7 | 2021 | 20660 | 0.140 |
Why?
|
Radiometry | 1 | 2022 | 804 | 0.140 |
Why?
|
Molecular Probes | 1 | 2018 | 307 | 0.140 |
Why?
|
Lung Diseases | 2 | 2019 | 1940 | 0.140 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15880 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4405 | 0.130 |
Why?
|
Galectin 3 | 1 | 2018 | 238 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1181 | 0.130 |
Why?
|
Sepsis | 2 | 2021 | 2606 | 0.130 |
Why?
|
Myofibroblasts | 1 | 2017 | 229 | 0.130 |
Why?
|
Biopsy | 3 | 2022 | 6763 | 0.130 |
Why?
|
Plasma Cells | 1 | 2018 | 591 | 0.120 |
Why?
|
Bronchiectasis | 1 | 2016 | 141 | 0.120 |
Why?
|
Fibroblasts | 2 | 2023 | 4159 | 0.120 |
Why?
|
Obesity Hypoventilation Syndrome | 1 | 2014 | 17 | 0.110 |
Why?
|
Immunosuppressive Agents | 5 | 2024 | 4209 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10383 | 0.110 |
Why?
|
Cyclophosphamide | 3 | 2024 | 2228 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1628 | 0.110 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2017 | 618 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1801 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1339 | 0.100 |
Why?
|
Shock, Septic | 1 | 2019 | 774 | 0.100 |
Why?
|
Prone Position | 1 | 2014 | 201 | 0.100 |
Why?
|
Breath Tests | 1 | 2014 | 297 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2019 | 22222 | 0.100 |
Why?
|
Female | 18 | 2024 | 396101 | 0.100 |
Why?
|
Male | 18 | 2024 | 363691 | 0.100 |
Why?
|
Endothelial Cells | 2 | 2022 | 3584 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1365 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1240 | 0.100 |
Why?
|
Tidal Volume | 1 | 2014 | 519 | 0.090 |
Why?
|
Aged | 11 | 2024 | 171114 | 0.090 |
Why?
|
Patient Positioning | 1 | 2014 | 328 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1008 | 0.090 |
Why?
|
Forced Expiratory Volume | 1 | 2016 | 1828 | 0.090 |
Why?
|
Critical Illness | 2 | 2021 | 2744 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1461 | 0.090 |
Why?
|
Disease Progression | 5 | 2024 | 13631 | 0.080 |
Why?
|
Antigens, CD | 1 | 2020 | 4025 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1663 | 0.080 |
Why?
|
Middle Aged | 12 | 2024 | 223004 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1088 | 0.080 |
Why?
|
Autonomic Nervous System | 1 | 2014 | 706 | 0.080 |
Why?
|
Prognosis | 3 | 2023 | 29921 | 0.080 |
Why?
|
Contrast Media | 2 | 2020 | 5329 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59488 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2024 | 81515 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2659 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7425 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2016 | 1311 | 0.070 |
Why?
|
Polysomnography | 1 | 2013 | 1859 | 0.070 |
Why?
|
United States | 3 | 2024 | 72898 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2019 | 3800 | 0.060 |
Why?
|
Quality of Life | 5 | 2024 | 13461 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12976 | 0.060 |
Why?
|
Risk Factors | 3 | 2024 | 74836 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9514 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2014 | 997 | 0.060 |
Why?
|
Skin | 1 | 2017 | 4489 | 0.050 |
Why?
|
Bronchoalveolar Lavage | 1 | 2023 | 131 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2014 | 2709 | 0.050 |
Why?
|
Heart Rate | 1 | 2014 | 4203 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 263 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2024 | 346 | 0.050 |
Why?
|
Animals | 7 | 2023 | 168759 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 283 | 0.050 |
Why?
|
Vital Capacity | 1 | 2024 | 995 | 0.040 |
Why?
|
Bleomycin | 1 | 2022 | 491 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2017 | 7851 | 0.040 |
Why?
|
Hypertrophy | 1 | 2022 | 559 | 0.040 |
Why?
|
Therapeutic Equipoise | 1 | 2019 | 29 | 0.040 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 32 | 0.040 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 30 | 0.040 |
Why?
|
Peroxidase | 1 | 2023 | 606 | 0.040 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2021 | 199 | 0.040 |
Why?
|
Sphingosine | 1 | 2022 | 306 | 0.040 |
Why?
|
Exoribonucleases | 1 | 2019 | 88 | 0.040 |
Why?
|
Mucin-5B | 1 | 2019 | 148 | 0.040 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2019 | 62 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2019 | 122 | 0.040 |
Why?
|
Immunosorbent Techniques | 1 | 2018 | 173 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 59886 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65189 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39194 | 0.040 |
Why?
|
Electroencephalography | 1 | 2013 | 6273 | 0.040 |
Why?
|
Mice | 5 | 2023 | 81818 | 0.040 |
Why?
|
Hemoptysis | 1 | 2019 | 150 | 0.040 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 553 | 0.040 |
Why?
|
Sample Size | 1 | 2020 | 845 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4528 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 41647 | 0.030 |
Why?
|
Adult | 6 | 2021 | 223038 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 465 | 0.030 |
Why?
|
Matrix Metalloproteinases | 1 | 2018 | 392 | 0.030 |
Why?
|
Exocytosis | 1 | 2017 | 323 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2019 | 568 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20125 | 0.030 |
Why?
|
Sex Distribution | 1 | 2021 | 2263 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2022 | 1166 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 584 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11840 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 852 | 0.030 |
Why?
|
Resuscitation | 1 | 2019 | 679 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2615 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1995 | 0.030 |
Why?
|
Gene Deletion | 1 | 2022 | 2666 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 749 | 0.030 |
Why?
|
Integrins | 1 | 2018 | 840 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 852 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8626 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 816 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1145 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54806 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2019 | 532 | 0.030 |
Why?
|
Respiration | 1 | 2020 | 1653 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 209 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18294 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8927 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1315 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3211 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1481 | 0.020 |
Why?
|
Protein Transport | 1 | 2017 | 1938 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14652 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3426 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 22331 | 0.020 |
Why?
|
Artifacts | 1 | 2020 | 1893 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2194 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2536 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4642 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2717 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9550 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4913 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3956 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6493 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6208 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4772 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2411 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5786 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5501 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3655 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4034 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 5596 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7478 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8041 | 0.010 |
Why?
|
Acute Disease | 1 | 2015 | 7232 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13266 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15398 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6610 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16721 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10429 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14447 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18973 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9649 | 0.010 |
Why?
|
Obesity | 2 | 2014 | 13075 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6404 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8733 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12807 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3247 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18071 | 0.010 |
Why?
|
Adolescent | 1 | 2014 | 88832 | 0.000 |
Why?
|
Neoplasms | 1 | 2013 | 22340 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_